Why the study?
Does muscle computed tomography demonstrate motor neuron disease in patients with late-onset GM2 gangliosidosis?
Does muscle computed tomography demonstrate motor neuron disease in patients with late-onset GM2 gangliosidosis?
Muscle computed tomography reveals diffuse muscle wasting and fatty replacement in late-onset GM2 gangliosidosis, indicating that progressive motor disability is mainly due to motor neuron disease.
Answers are grounded in this paper and cite their sources.
May indicate motor neuron disease drives disability in late-onset GM2 gangliosidosis; hypothesis-generating and requires larger studies before clinical adoption.
Late-onset GM2 gangliosidosis, a rare inherited neuronal storage disease, is characterized by a variety of clinical manifestations. The common clinical picture comprises neuromuscular, spinocerebellar, extrapyramidal, cognitive, and psychiatric abnormalities. Details of the extent of muscle involvement have never been reported. Eight patients with this syndrome were evaluated for the existence and extent of motor neuron disease using routine electrodiagnosis and systematic evaluation of skeletal musculature by computed tomography. Motor neuron disease was present in each and every patient regardless of the clinical manifestations and to a degree beyond that suspected on neurological examination. Muscle imaging disclosed a diffuse wasting and fatty replacement of muscles with predilection of pelvic and thigh muscles, and especially the quadriceps group. It seems that progressive motor disability in this syndrome is mainly due to motor neuron disease, as manifested by muscle atrophy, which can be easily demonstrated by muscle computed tomography.
No takes yet. Share an insight, caveat, or question.
Streifler et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: